A commitment without a target, a shifting landscape, dollars in diagnostics . . . We’re reading about antimicrobial resistance and baby steps

By on .

NewWWRUN declaration on antimicrobial resistance lacks targets – While the 700,000 people who die of drug-resistant infections worldwide annually could increase to 10 million without concerted and collaborative action over the next few decades, the commitment finalized at the recent United Nations High-Level meeting to address the problem doesn’t ask much of the nations signing onto it, and thus is unlikely to get much, advocates and observers quoted in this article say. That, observers note, is because the political declaration signed by member states does not set the quantified goals that are necessary to establishing accountability — and funding. But, Center for Disease Dynamics, Economics and Policy Director Ramanan Laxminarayan says, acknowledgement of the problem still represents a step forward.

National Action Plan for Combating Multidrug-Resistant Tuberculosis: Six Month Progress Report and Future Direction – Similarly, when the White House released its National Action Plan for Combating Multidrug-Resistant Tuberculosis last year, global health advocates wondered if it would meet the fate of its 1992 predecessor by the same name — and be remembered for what it might have accomplished, if only it had been adequately funded. That still remains a question, unanswered in this slender update, which highlights hopes that attention paid will pay off, saying “the international landscape for action has begun to shift.”

Tuberculosis Diagnostics Market Worth $3.1 Billion by 2014 -This business story highlights one way attention to the conditions fueling drug-resistance has paid off, saying rising rates of screening for tuberculosis and a push for point of care diagnostic tools has fueled demand that promises returns for research, development and distribution of new tests.


Leave a Comment

Your email address will not be published. Required fields are marked *